Ingen internetforbindelse — viser den gemte version af siden.

Zimmer Biomet Hol…

USUSD
← Til Screeneren

Zimmer Biomet Holdings Inc (MI:1ZBH) — Industrial Specialties. Antal børser, hvor selskabets aktier handles: 3. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om Virksomheden

Websted
zimmer.com
Sektor
Health Care · Industrial Specialties
Hovedkontor
WARSAW, United States
Administrerende Direktør
Ivan Tornos
Ansatte
17 000
Grundlagt
1927
Udestående Aktier
190.74 mio. pr. 2026-07-30
Et År: −3.7% · 3 år: −8.7% · 5 år: −8.7% (uden aktiesplit)
DatoAktierÆndring
30.07.2026190.74 mio.−1.4%tilbagekøb
23.04.2026193.46 mio.−1.1%tilbagekøb
10.02.2026195.65 mio.−1.3%tilbagekøb
31.10.2025198.18 mio.+0.04%ingen væsentlige ændringer
31.07.2025198.1 mio.+0.1%udstedelse (udvanding)
24.04.2025197.85 mio.−0.6%tilbagekøb
14.02.2025199.06 mio.—ingen væsentlige ændringer
25.10.2024199.07 mio.−2.2%tilbagekøb
31.07.2024203.65 mio.−1.0%tilbagekøb
22.04.2024205.73 mio.+0.3%udstedelse (udvanding)
14.02.2024205.08 mio.−1.9%tilbagekøb
02.11.2023208.98 mio.—ingen væsentlige ændringer
26.07.2023208.96 mio.+0.2%udstedelse (udvanding)
21.04.2023208.57 mio.−0.2%tilbagekøb
07.02.2023208.98 mio.−0.4%tilbagekøb
Antal aktier ifølge virksomhedens rapporter. Et aktiesplit registreres ved et spring i antallet med et helt multiplum.
Free Float
190.13 mio.
Markedsværdi
17.48 mia. USD
Insidere
0.16%
Institutionelle Investorer
111.42%
Branche (SIC)
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Juridisk Form
XTIQ
ISIN
US98956P1021
LEI
2P2YLDVPES3BXQ1FRB91
P/E
22.9
Udbetalingsgrad
23.4%
FCF
1.52 mia. USD
Udbetaling / FCF
12%
Gæld
7.48 mia. USD
4.6 år FCF
Udbyttestreak
14 år
Indtjening, FCF og udbetalt udbytte — for de 12 måneder frem til 30.06.2026 (selskabets seneste rapport).
NAV
66.18 USD · P/NAV 1.39
Balancedato30.06.2026
Aktiver22.8 mia. USD
− Forpligtelser10.2 mia. USD
= Total Egenkapital12.6 mia. USD
− Ikke-Kontrollerende Interesser8.60 mio. USD
= NAV (aktiekapital i selskabets aktionærer)12.6 mia. USD
− Goodwill9.92 mia. USD
− Immaterielle Aktiver4.46 mia. USD
= Materiel NAV−1.76 mia. USD
Aktier190 737 689
NAV pr. Aktie66.18 USD
Håndgribelig NAV pr. Aktie−9.21 USD
Aktiekurs (1ZBH)80.9600 EUR
P/NAV1.39
NAV-Historie
BalancedatoNAVNAV pr. Aktie
30.06.202612.6 mia. USD66.18 USD
31.03.202612.7 mia. USD65.51 USD
31.12.202512.7 mia. USD64.90 USD
30.09.202512.8 mia. USD64.37 USD
30.06.202512.5 mia. USD63.23 USD
31.03.202512.4 mia. USD62.65 USD
31.12.202412.5 mia. USD62.63 USD
30.09.202412.4 mia. USD62.16 USD
Beskrivelse

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

annonce

Børser og Tickere

BørsTickerValutaPrisType
US USA StocksZBH primærUSD98.81 +4.16%almindelige aktier
MI Borsa Italiana (Milan)1ZBH sekundærEUR80.96 +0.00%almindelige aktier
VI Vienna Stock ExchangeZBH sekundærEUR84.44 -0.07%almindelige aktier

Kurs over 3 Måneder

stigningsdag faldsdag udbyttets ex-dato udbetalingsdatoHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Udbytte

Pr. År, US:ZBH: 0.96 USD (4 udb.)

Zimmer Biomet Holdings Inc (ZBH) udbetaler udbytte kvartalsvis. Pr. År (12 måneder op til og med den senest annoncerede betaling): 0.96 USD pr. Aktie (betalinger: 4). Det svarer til cirka 0.97% af den nuværende aktiekurs. Baseret på betalingshistorikken forventes næste ex-udbyttedato omkring 30.12.2026. Uafbrudt udbyttehistorik: 14 år.

Ex-DatoUdbetalingBeløb%TypeTicker
2026-09-302026-10-300.2400 USD0.3/1.1 %kvartalsvisUS:ZBH
2026-06-252026-07-310.2400 USD0.3/1.1 %kvartalsvisUS:ZBH
2026-03-312026-04-300.2400 USD0.3/1.1 %kvartalsvisUS:ZBH
2025-12-302026-01-300.2400 USD0.3/1.1 %kvartalsvisUS:ZBH
2025-09-302025-10-310.2400 USD0.2/1.0 %kvartalsvisUS:ZBH
2025-06-262025-07-310.2400 USD0.3/1.0 %kvartalsvisUS:ZBH
2025-03-312025-04-300.2400 USD0.2/0.9 %kvartalsvisUS:ZBH
2024-12-302025-01-310.2400 USD0.2/0.9 %kvartalsvisUS:ZBH
2024-09-302024-10-310.2400 USD0.2/1.0 %kvartalsvisUS:ZBH
2024-06-262024-07-310.2400 USD0.2/≈1.0 %kvartalsvisUS:ZBH
2024-03-272024-04-300.2400 USD0.2/≈1.0 %kvartalsvisUS:ZBH
2023-12-262024-01-310.2400 USD0.2/≈1.0 %kvartalsvisUS:ZBH

Største Ejere

EjerAndelAktierRapportdato
Dodge & Cox Inc.12.65%24.12 mio.2026-06-30
Blackrock Inc.8.19%15.61 mio.2026-06-30
Dodge & Cox Funds-Dodge…8.15%15.55 mio.2026-06-30
Harris Associates L.P.6.68%12.74 mio.2026-06-30
Vanguard Capital Managem…6.62%12.63 mio.2026-06-30
Capital International In…6.39%12.18 mio.2026-06-30
State Street Corporation4.65%8.88 mio.2026-06-30
Vanguard Portfolio Manag…4.43%8.44 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…3.22%6.14 mio.2026-06-30
VANGUARD WINDSOR FUNDS-V…3.02%5.75 mio.2026-04-30
HARRIS ASSOCIATES INVEST…2.95%5.62 mio.2026-06-30
Geode Capital Management…2.8%5.35 mio.2026-06-30
VANGUARD INDEX FUNDS-Van…2.63%5.01 mio.2026-06-30
WASHINGTON MUTUAL INVEST…2.59%4.93 mio.2026-06-30
Price (T.Rowe) Associate…2.52%4.8 mio.2026-06-30
Invesco Ltd.2.09%3.98 mio.2026-06-30
Growth Fund of America1.96%3.74 mio.2026-06-30
VanEck ETF Trust-VanEck…1.58%3.01 mio.2026-08-31
iShares Trust-iShares Co…1.37%2.61 mio.2026-07-31
Fidelity Concord Street…1.31%2.5 mio.2026-07-31
TORNOS IVAN (Chief Execu…≈0.04%83 1912026-03-06
UPADHYAY SUKETU P (Chief…≈0.04%69 4852026-03-06
PHIPPS CHAD F (Officer)≈0.03%65 2312026-09-04
VAN ZUILEN WILFRED (Offi…≈0.02%30 9912026-03-06
YI SANG (Officer)≈0.01%27 2512026-05-29
BEZJAK MARK (Officer)≈0.01%13 1342025-03-06
ELLINGSON RACHEL H. (Off…≈0.01%11 9062025-02-20
WINKLER LORI (Officer)≈0.01%10 2242026-03-12
STELLATO PAUL A (Officer…≈0%5 5822026-03-06
NOOR JEHANZEB (Officer)≈0%5 1512026-04-01